Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001567619-21-020783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-18 | 2021-11-16 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $158.83 | -5,000 | 352.8K | -1% | -$794.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-16 | S | D | 800 | $157.55 | 355,816 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $157.02 to $157.845. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-11-16 | S | D | 100 | $160.32 | 351,616 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-11-16 | S | D | 1,048 | $159.80 | 351,716 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $159.23 to $160.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-11-16 | S | D | 3,052 | $158.79 | 352,764 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $158.19 to $159.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |